These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 6016918

  • 41. [Clinical cases on the use of a combination of substances with hepatoprotective and detoxicant action in the treatment of some acute and chronic liver diseases].
    Ivaldi A.
    Minerva Med; 1967 Apr 28; 58(34 Suppl):1618-20. PubMed ID: 4226049
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS, Nikolaeva AP, Bendikov EA, Blok IuE, Sukhareva GV.
    Sov Med; 1989 Apr 28; (7):79-81. PubMed ID: 2799537
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Clinical experience in the treatment of chronic liver diseases with Solcohepsyl extralysate].
    Arias Vallejo E.
    Folia Clin Int (Barc); 1966 Sep 28; 16(9):404-15. PubMed ID: 5990974
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [On the therapeutic value of some amino acids in combination with vitamin B 12, folic acid and nicotinamide in the therapy of hepatic insufficiency].
    Meneghini P, Avanzi G.
    Minerva Med; 1967 Apr 28; 58(34 Suppl):1596-603. PubMed ID: 4226045
    [No Abstract] [Full Text] [Related]

  • 50. [Biological evaluation of liver protective agents with special consideration of liver preparations. 9. Practical use of prepared methods for biological evaluation of commercial liver preparations].
    Dressel H, Richter J.
    Pharmazie; 1969 Sep 09; 24(9):555-66. PubMed ID: 5368430
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Trial of LL 650 in various hepatic diseases].
    Savoye B, Dietsch R, Chapuy M, Girard M.
    J Med Lyon; 1972 May 05; 53(228):675-6 passim. PubMed ID: 5084113
    [No Abstract] [Full Text] [Related]

  • 53. [Uridine-diphospho-glucose in the treatment of viral hepatitis].
    Pasquale A, Cerutti L, Soranzo L.
    Minerva Med; 1969 Dec 12; 60(99):4985-98. PubMed ID: 5363066
    [No Abstract] [Full Text] [Related]

  • 54. [Clinico-metabolic observations on the use in therapy of a combination of vitamin B-12, folic acid, nicotinamide and amino acids of the arginine group in patients with chronic liver diseases].
    Piro E, Nicoletti A, Ruffolo S.
    Minerva Med; 1967 Apr 28; 58(34 Suppl):1629-33. PubMed ID: 4226052
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Experimental clinical research on the therapeutic action of AM 65234].
    Forattini C, Pulliero G.
    Clin Ter; 1966 Jul 15; 38(1):55-68. PubMed ID: 5990473
    [No Abstract] [Full Text] [Related]

  • 57. [Treatment of liver cirrhosis and chronic liver diseases with total liver extract].
    Borgo E.
    Minerva Med; 1965 Nov 03; 56(88):3735-9. PubMed ID: 5846626
    [No Abstract] [Full Text] [Related]

  • 58. [Association of nucleosides in the treatment of liver diseases].
    Indiveri F, Rolandi E.
    Minerva Med; 1966 Feb 10; 57(12):451-5. PubMed ID: 5910814
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Clinical considerations on the therapeutic action of Nucleodoxine].
    Idéo G.
    Omnia Med Ther; 1968 Feb 10; 46(2):409-15. PubMed ID: 5739611
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.